Impact of postoperative c-reactive protein level on recurrence and prognosis in patients with N0M0 clear cell renal cell carcinoma

Journal of Urology

Volumn 186, Issue 2, 2011, Pages 430-435

  Ito, Keiichi ^a   Yoshii, Hidehiko ^a   Sato, Akinori ^a   Kuroda, Kenji ^a   Asakuma, Junichi ^a   Horiguchi, Akio ^a   Sumitomo, Makoto ^a   Asano, Tomohiko ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

C reactive protein; carcinoma; kidney; mortality; neoplasm metastasis; renal cell

Indexed keywords

C REACTIVE PROTEIN; RADIOISOTOPE;

ABDOMINAL RADIOGRAPHY; ANEMIA; ARTICLE; BONE SCINTISCANNING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL RENAL CELL CARCINOMA; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); DISTANT METASTASIS; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LABORATORY TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MICROVASCULARIZATION; MULTIVARIATE ANALYSIS; NEPHRECTOMY; OVERALL SURVIVAL; PARTIAL NEPHRECTOMY; PATIENT COUNSELING; PATIENT MONITORING; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RISK ASSESSMENT; SURVIVAL RATE; THORAX RADIOGRAPHY; THROMBOCYTOSIS; TUMOR NECROSIS;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 79960186084     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.03.113     Document Type: Article

References (25)

1. W.M. Linehan, M.M. Walther, and R.B. Alexander Adoptive immunotherapy of renal cell carcinoma: studies from the Surgery Branch, National Cancer Institute Semin Urol 11 1993 41
2. R.M. Bukowski Prognostic factors for survival in metastatic renal cell carcinoma: update 2008 Cancer 115 2009 2273
3. L. Schips, K. Lipsky, and R. Zigeuner Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patients Urology 62 2003 1024
4. J.Y. Blay, J.F. Rossi, and J. Wijdenes Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma Int J Cancer 72 1997 424
5. B. Ljungberg, K. Grankvist, and T. Rasmuson Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma Eur J Cancer 33 1997 1794
6. J.Y. Blay, S. Negrier, and V. Combaret Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma Cancer Res 52 1992 3317
7. M.M. Walther, B. Johnson, and D. Culley Serum interleukin-6 levels in metastatic renal cell carcinoma before treatment with interleukin-2 correlates with paraneoplastic syndromes but not patient survival J Urol 159 1998 718
8. M. Oya, A. Takayanagi, and A. Horiguchi Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma Carcinogenesis 24 2003 377
9. S. Ramsey The role of the systemic inflammatory response as a biomarker in immunotherapy for renal cell cancer Mol Diagn Ther 13 2009 277
10. I. Kedar, W. Mermershtain, and H. Ivgi Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy Int J Cancer 110 2004 260
11. W.J. Jabs, B.A. Lögering, and P. Gerke The kidney as a second site of human C-reactive protein formation in vivo Eur J Immunol 33 2003 152
12. W.J. Jabs, M. Busse, and S. Krger Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue Kidney Int 68 2005 2103
13. K. Ito, T. Asano, and H. Yoshii Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma Int J Urol 13 2006 1365
14. P.I. Karakiewicz, G.C. Hutterer, and Q.D. Trinh C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients Cancer 110 2007 1241
15. S.P. Jagdev, W. Gregory, and N.S. Vasudev Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein Br J Cancer 103 2010 1649
16. Y. Komai, K. Saito, and K. Sakai Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma BJU Int 99 2007 77
17. G.W. Lamb, P.A. McArdle, and S. Ramsey The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer BJU Int 102 2008 756
18. S. Ramsey, G.W. Lamb, and M. Aitchison Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer BJU Int 101 2008 959
19. M. Tatokoro, K. Saito, and Y. Iimura Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy J Urol 180 2008 515
20. K. Saito, M. Tatokoro, and Y. Fujii Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma Eur Urol 55 2009 1145
21. T.V. Johnson, A. Abbasi, and A. Owen-Smith Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma Urology 76 2010 766
22. K. Ito, H. Yoshii, and J. Asakuma Clinical impact of the presence of the worst nucleolar grade in renal cell carcinoma specimens Jpn J Clin Oncol 39 2009 588
23. R.J. Motzer, J. Bacik, and L.H. Schwartz Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma J Clin Oncol 22 2004 454
24. L. Alberti, M.C. Thomachot, and T. Bachelot IL-6 as an intracrine growth factor for renal carcinoma cell lines Int J Cancer 111 2004 653
25. S. Naito, N. Yamamoto, and T. Takayama Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients Eur Urol 57 2010 317